[Prevention and control fo side effects in the chemotherapy of advanced lung cancer].
The side effects of chemotherapy in lung cancer are reviewed and a methodological scheme proposed to prevent and monitor them by means of scrupulous preliminary selection. This is done by studying heart, liver and renal function, as well as by screening the patient's immunity condition. The side-effects of chemotherapy are monitored by monthly repetition of the above tests. Personal cases showing the good results obtained are reported.
D000368:Aged; D000917:Antibody Formation; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001500:BCG Vaccine / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000175:diagnosis; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D008107:Liver Diseases / Q000175:diagnosis; D008213:Lymphocyte Activation; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D010612:Pharyngitis / Q000517:prevention & control; D011379:Prognosis; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001500:BCG Vaccine; D014750:Vincristine; D003520:Cyclophosphamide; D008727:Methotrexate
Metologia di prevenzione e controllo degli effetti collaterali della chemio-terapia del cancro del polmone in fase avanzata.